
|Poll|January 20, 2021
Discussions With Patients: Medical Marijuana
Author(s)Psychiatric Times Editors
As our knowledge about herbal cannabis, the endocannabinoid system, and cannabinoid pharmacology expands, should psychiatrists discuss these issues with their patients?
Advertisement
Do you discuss medical marijuana/cannabis use for medical/psychiatric issues with your patients?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Interdisciplinary Consensus Guidelines on Stuttering (Childhood-Onset Fluency Disorder): Addressing Issues in Diagnosis, Treatment, and Unmet Needs
2
DT120 (Lysergide) Shows Rapid, Lasting Relief for Generalized Anxiety in Phase 3 Trial
3
TRD: Matching Patients to the Right Treatment
4
New in Narcolepsy: Pharmacology Updates
5










